0
0
A groundbreaking clinical trial in Japan has demonstrated that a vitamin B3 derivative can significantly improve the health of patients suffering from Werner syndrome, a rare genetic disorder that causes rapid and premature aging, often beginning in their twenties. The study, published in Aging Cell, marks a major step forward in the treatment of this devastating condition, which typically leads to severe health complications and shortened life expectancy.
Researchers at Chiba University, led by Associate Professor Masaya Koshizaka, conducted a double-blind, randomized crossover trial involving nine patients. Each participant received either nicotinamide riboside (NR), a form of vitamin B3, or a placebo for 26 weeks, then switched treatments for another 26 weeks. The results were striking: during the NR treatment phases, patients experienced measurable improvements in cardiovascular health, wound healing, and kidney function compared to the placebo periods.
Werner syndrome is caused by mutations in the WRN gene, which normally helps maintain DNA integrity and cellular energy metabolism. When this gene malfunctions, cells struggle to produce sufficient NAD+, a molecule vital for energy production and DNA repair. This leads to a cellular energy crisis that accelerates aging, manifesting as gray hair, cataracts, diabetes, and cardiovascular disease decades earlier than normal.
The trial found that NR supplementation significantly increased NAD+ levels in patients’ blood, correlating with the observed health improvements. The crossover design allowed each patient to serve as their own control, strengthening the evidence for NR’s therapeutic effects. When receiving placebo, patients’ health markers declined, but during NR treatment, these same individuals showed clear improvements in arterial stiffness, wound healing, and kidney function.
While the study’s sample size was small, its findings are considered highly promising. The research not only offers new hope for those with Werner syndrome but also provides valuable insights into the biology of aging and potential interventions for age-related decline in the broader population5. The team hopes their work will accelerate studies on other premature aging disorders and common age-related diseases, with the ultimate goal of extending health span and improving quality of life.
Disclaimer:
The information in this article is based on recent scientific research and is intended for informational purposes only. The findings are preliminary and involve a small number of participants. Consult a qualified healthcare professional before starting any new supplement or treatment regimen. This article does not constitute medical advice.
